First Interstate Bank Gilead Sciences, Inc. Transaction History

First Interstate Bank

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $295,988 - $333,371	-5,128 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $297,013 - $372,190	5,128 New	5,128 $305,000
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $435,321 - $547,340	-7,010 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $5.31 Million - $6.16 Million	-73,347 Reduced 91.28%	7,010 $539,000
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $353,295 - $452,521	-5,641 Reduced 6.56%	80,357 $6.01 Million
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $488,400 - $537,224	-7,926 Reduced 8.44%	85,998 $5.59 Million
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $199,656 - $220,386	-3,194 Reduced 3.29%	93,924 $5.95 Million
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $223,721 - $250,878	-3,616 Reduced 3.59%	97,118 $6.56 Million
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $162,452 - $181,989	-2,598 Reduced 2.51%	100,734 $6.55 Million
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $184,041 - $240,160	-3,040 Reduced 2.86%	103,332 $6.46 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $205,714 - $227,763	-2,886 Reduced 2.64%	106,372 $8.21 Million
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $380,456 - $443,787	-5,864 Reduced 5.09%	109,258 $7.74 Million
Q1 2018 Apr 26, 2018	SELL	$72.84 - $88.8 $316,562 - $385,924	-4,346 Reduced 3.64%	115,122 $8.68 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $168,412 - $197,691	2,367 Added 2.02%	119,468 $8.56 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $8.44 Million - $10 Million	117,101	117,101 $9.49 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

Stay updated on First Interstate Bank with notifications on news.